IPCA Laboratories Limited has informed the Exchange regarding 'Sale of 100% equity shares of wholly owned step-down subsidiary and Updation of Registered Office Address
13 Jan, 2026 | 11:16am • Source: NSE
IPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on January 13, 2026
13 Jan, 2026 | 11:04am • Source: NSE
Sale of 100% equity shares of wholly owned step-down subsidiary and updation of Registered Office Address
13 Jan, 2026 | 10:54am • Source: BSE
Updation in Registered Office Address
13 Jan, 2026 | 10:44am • Source: BSE
Outcome of Board Meeting
13 Jan, 2026 | 10:40am • Source: BSE
The Company has enclosed herewith RTA Certificate for the quarter ended 31.12.2025.
08 Jan, 2026 | 11:44am • Source: BSE
IPCA Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
22 Dec, 2025 | 10:41am • Source: NSE
Inspection of Company''s Active Pharmaceutical Ingredients (APIs) manufacturing facility situated at Tarapur (Palghar-Maharashtra) by US FDA
05 Dec, 2025 | 02:30pm • Source: BSE
Clarification sought on Volume Movement
17 Nov, 2025 | 02:09pm • Source: BSE
The Exchange has sought clarification from Ipca Laboratories Ltd on November 17, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.
17 Nov, 2025 | 01:55pm • Source: BSE
Transcript of the Conference Call held on 13th November, 2025
17 Nov, 2025 | 01:04pm • Source: BSE
Copy of Newspaper Publication
14 Nov, 2025 | 03:10pm • Source: BSE
IPCA Laboratories Limited has informed the Exchange about the revised Schedule of meet
12 Nov, 2025 | 10:18am • Source: NSE
Conference Call for Q2FY26 Results
12 Nov, 2025 | 10:09am • Source: BSE
Conference Call to discuss Q2FY26 Results
06 Nov, 2025 | 12:46pm • Source: BSE
Slump Sale of Company''s API and Drug Intermediates Manufacturing unit situated at Ankleshwar
17 Oct, 2025 | 05:27pm • Source: BSE
Outcome of Board Meeting
17 Oct, 2025 | 05:24pm • Source: BSE
Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...
17 Oct, 2025 | 03:45pm • Source: BSE
IPCA Laboratories Limited has informed the Exchange about incorporation of new subsidiary in Germany
16 Oct, 2025 | 11:13am • Source: NSE